LIMN Stock Analysis: Buy, Sell, or Hold?
LIMN - Liminatus Pharma, Inc. Class A Common Stock
$0.14
0.03 (24.13%)
▲
5d:
+43.94%
30d:
-26.92%
90d:
-16.67%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Jun 30, 2026
0d
Get Alerted When LIMN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: LIMN shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: LIMN shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: LIMN is currently trading at $0.14, which is considered fair relative to its 30-day fair value range of $0.11 to $0.16.
Technical Outlook: Technically, LIMN is in a downtrend. Immediate support is located at $0.13, while resistance sits at $0.21. The stock is showing strong short-term momentum, up 24.1% recently.
Market Sentiment: LIMN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, LIMN is in a downtrend. Immediate support is located at $0.13, while resistance sits at $0.21. The stock is showing strong short-term momentum, up 24.1% recently.
Market Sentiment: LIMN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.11 -
$0.16
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
91.2%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+24.1%)
Trading Range Analysis
30-Day Trading Range
$0.11 -
$0.16
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.13
Resistance Level
$0.21
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Share & Embed Analysis
Last updated: July 02, 2026 10:43 PM ET
Data refreshes hourly during market hours. Next update: 11:43 PM
Data refreshes hourly during market hours. Next update: 11:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LIMN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 63 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 51 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 55 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 64 BUY |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$123 | 57 HOLD |